ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,639 | -74.1% | 95,897 | -11.5% | 0.00% | – |
| Q2 2023 | $48,775 | -30.6% | 108,312 | -2.9% | 0.00% | -100.0% |
| Q1 2023 | $70,292 | +25.4% | 111,574 | -0.9% | 0.00% | -66.7% |
| Q4 2022 | $56,073 | -72.8% | 112,574 | -5.7% | 0.00% | +50.0% |
| Q3 2022 | $206,000 | +26.4% | 119,374 | -9.7% | 0.00% | +100.0% |
| Q2 2022 | $163,000 | +3.2% | 132,130 | -45.4% | 0.00% | 0.0% |
| Q1 2022 | $158,000 | -37.8% | 242,154 | +3.7% | 0.00% | -50.0% |
| Q4 2021 | $254,000 | -59.7% | 233,504 | -32.7% | 0.00% | -50.0% |
| Q3 2021 | $631,000 | +6.8% | 347,167 | +55.0% | 0.00% | -20.0% |
| Q2 2021 | $591,000 | -40.9% | 223,924 | -19.3% | 0.01% | -50.0% |
| Q1 2021 | $1,000,000 | +50.4% | 277,609 | +5.1% | 0.01% | +42.9% |
| Q4 2020 | $665,000 | +15.5% | 264,214 | +30.5% | 0.01% | 0.0% |
| Q3 2020 | $576,000 | -10.1% | 202,441 | +3.6% | 0.01% | -22.2% |
| Q2 2020 | $641,000 | +30.8% | 195,441 | -2.3% | 0.01% | 0.0% |
| Q1 2020 | $490,000 | -48.0% | 200,141 | +0.2% | 0.01% | -40.0% |
| Q4 2019 | $942,000 | +8.9% | 199,707 | +0.7% | 0.02% | +15.4% |
| Q3 2019 | $865,000 | +56.1% | 198,357 | +108.6% | 0.01% | +30.0% |
| Q2 2019 | $554,000 | +99.3% | 95,086 | +31.7% | 0.01% | +100.0% |
| Q1 2019 | $278,000 | +5.3% | 72,192 | -48.8% | 0.01% | -16.7% |
| Q4 2018 | $264,000 | -29.0% | 141,132 | +21.5% | 0.01% | -25.0% |
| Q3 2018 | $372,000 | +6.0% | 116,166 | +29.9% | 0.01% | -42.9% |
| Q1 2018 | $351,000 | +20.2% | 89,440 | +84.2% | 0.01% | +100.0% |
| Q3 2017 | $292,000 | +7.7% | 48,567 | +5.7% | 0.01% | 0.0% |
| Q2 2017 | $271,000 | +4.2% | 45,949 | +10.6% | 0.01% | 0.0% |
| Q1 2017 | $260,000 | +42.9% | 41,541 | +23.4% | 0.01% | +16.7% |
| Q4 2016 | $182,000 | -38.5% | 33,666 | -35.8% | 0.01% | -50.0% |
| Q3 2016 | $296,000 | -33.3% | 52,454 | -29.5% | 0.01% | -33.3% |
| Q2 2016 | $444,000 | -11.2% | 74,433 | +10.6% | 0.02% | -25.0% |
| Q1 2016 | $500,000 | +56.7% | 67,320 | +75.4% | 0.02% | +60.0% |
| Q4 2015 | $319,000 | – | 38,373 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |